Companies / PFE vs LLY
PFE vs LLY: Pfizer and Eli Lilly
Pfizer (PFE) reported $62.6B in revenue against a 12.4% net margin, while Eli Lilly (LLY) reported $65.2B at a 31.7% net margin, most recently.
| Metric | PFE | LLY |
|---|---|---|
| Revenue | $62.6B | $65.2B |
| Net Income | $7.8B | $20.6B |
| Gross Margin | 74.3% | 83.0% |
| Operating Margin | — | — |
| EPS (Diluted) | $1.36 | $22.95 |
| Free Cash Flow | $9.1B | — |
| Total Debt | $64.8B | $42.5B |
| P/E Ratio | 18.3× | 46.9× |
| P/B Ratio | n/m | n/m |
| Stock Price | $29.90 | $1375.19 |
Free: last 5 years
| Fiscal year | FY2007 🔒 | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $81.3B | $101.2B | $59.6B | $63.6B | $62.6B |
| LLY Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |